Journal for ImmunoTherapy of Cancer (Nov 2021)

156 RBC-derived, activating antigen carriers (SQZ AACs) prime potent T cell responses and drive tumor regression in vivo

  • Katarina Blagovic,
  • Armon Sharei,
  • Howard Bernstein,
  • Scott Loughhead,
  • Carolyne Smith,
  • Lindsay Moore,
  • Emrah Ilker Ozay

DOI
https://doi.org/10.1136/jitc-2021-SITC2021.156
Journal volume & issue
Vol. 9, no. Suppl 2

Abstract

Read online

No abstracts available.